Month: August 2014

August 7, 2014

Study tracks new end-stage renal disease therapy

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.

By Kathy Whitney
August 6, 2014

Football season opener to impact some parking

The Vanderbilt football season begins Aug. 28 with a nationally televised game against Temple University. As with last year’s season opener, the Thursday-evening game will require some minor adjustments to employee parking.

By VUMC News and Communications
August 6, 2014

External email tag being removed; users should continue to exercise caution

Vanderbilt IT removed the [External] tag from the subject lines of emails sent by Vanderbilt students through their Vanderbilt Gmail accounts effective Aug. 6, and will remove the tag from all other external emails on the evening of Aug. 11.

By VUMC News and Communications
August 6, 2014

Low selenium and lung cancer

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.

By Yan Su
August 5, 2014

Technique brings spinal cord neural signaling into focus

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.

By Bill Snyder
August 5, 2014

Drug discovery clues in network map

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.

By Bill Snyder
August 1, 2014

Kudos: Read about faculty, staff and student honors, awards and achievements

Read about faculty, staff and student honors, awards and achievements.
By VUMC News and Communications
August 1, 2014

VUMC resident physicians lead ‘Choosing Wisely’ initiative to reduce repetitive lab tests

A Vanderbilt University Medical Center initiative being led by teams of resident physicians is reducing repetitive lab tests and making a visible impact on health care delivery.
By Jessica Pasley
August 1, 2014

Radiation Oncology’s Malcolm to step down

Arnold Malcolm, M.D., MBA, the Cornelius Vanderbilt Professor of Radiation Oncology and chair of the department, will retire from his position as the department’s leader on Dec. 31, after serving in this role since August 2010.
By John Howser
August 1, 2014

Anti-inflammatory protein “rheostat” sheds light on leaky blood vessels

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.
By Emily Poulin
1 … 4 5 6